Orthocell Limited (ASX:OCC) Receives FDA Clearance for Remplir™
Orthocell (ASX:OCC) secures FDA clearance for Remplir™, enabling entry into the US $1.6 billion nerve repair market.
Category: Healthcare
Echo IQ (ASX:EIQ) Partners with Mayo Clinic Platform, Advances EchoSolv HF towards FDA Clearance
Echo IQ (ASX:EIQ) partners with Mayo Clinic Platform to advance EchoSolv HF and progress towards FDA clearance for its heart failure solution.
Cann Group Limited (ASX:CAN) Executes Supply Agreements with Chemist Warehouse
Cann Group Limited (ASX:CAN) signs supply agreements with Queensland’s Chemist Warehouse outlets to distribute its medicinal cannabis products.
Race Oncology (ASX:RAC) Activates First Australian Clinical Site for RC220 Trial
Race Oncology (ASX:RAC) initiates its first Australian clinical site for the Phase 1 RC220 trial, marking a significant step in advancing cancer treatment.
Bioxyne Limited (ASX:BXN) Signs Exclusive $7M Agreement with NectarTek
Bioxyne Limited (ASX:BXN) secures a $7 million manufacturing agreement with NectarTek, significantly increasing FY2026 revenue projections.
Biome Australia Limited (ASX:BIO) Secures $5.0M Debt Facility with NAB
Biome Australia Limited (ASX:BIO) secures a $5.0 million debt facility with NAB to drive growth and enhance financial stability.
Epsilon Healthcare Limited (ASX:EPN) Enters Voluntary Administration
Epsilon Healthcare Limited (ASX:EPN) enters voluntary administration, resulting in leadership changes and subdued operations.
Fisher & Paykel Healthcare (ASX:FPH) Addresses Impact of New US Tariffs
Fisher & Paykel Healthcare (ASX:FPH) outlines its response to new US tariffs, detailing operational and financial strategies.
Cochlear Limited (ASX:COH) Awaits Clarification on US Tariff
Cochlear Limited (ASX:COH) awaits clarification on new US export tariffs, expecting further details and market updates soon.
Biome Australia Limited (ASX:BIO) Reports Strong Q3 FY25 Sales Growth
Biome Australia (ASX:BIO) reports a 41% increase in Q3 FY25 sales revenue, highlighting strong growth and positive future outlook.